317 related articles for article (PubMed ID: 16972273)
1. Ubiquitin-proteasome system and Parkinson's disease.
Olanow CW; McNaught KS
Mov Disord; 2006 Nov; 21(11):1806-23. PubMed ID: 16972273
[TBL] [Abstract][Full Text] [Related]
2. Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease.
McNaught KS; Olanow CW
Neurobiol Aging; 2006 Apr; 27(4):530-45. PubMed ID: 16207501
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
Ross CA; Pickart CM
Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
[TBL] [Abstract][Full Text] [Related]
5. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
[TBL] [Abstract][Full Text] [Related]
6. Does smoking reduce the risk of Parkinson's disease through stimulation of the ubiquitin-proteasome system?
Chapman MA
Med Hypotheses; 2009 Dec; 73(6):887-91. PubMed ID: 19540050
[TBL] [Abstract][Full Text] [Related]
7. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
Hol EM; van Leeuwen FW; Fischer DF
Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
[TBL] [Abstract][Full Text] [Related]
8. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
Matsuda N; Tanaka K
J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies.
Lim KL
Expert Rev Proteomics; 2007 Dec; 4(6):769-81. PubMed ID: 18067415
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of Parkinson's disease.
Gandhi S; Wood NW
Hum Mol Genet; 2005 Sep; 14(18):2749-55. PubMed ID: 16126732
[TBL] [Abstract][Full Text] [Related]
11. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
[TBL] [Abstract][Full Text] [Related]
12. Does neurotrophic factor benefit to PD therapy via co-function with ubiquitin-proteasome system?
Niu C; Zhang J; Mei J; Fu X
Med Hypotheses; 2011 Apr; 76(4):589-92. PubMed ID: 21288653
[TBL] [Abstract][Full Text] [Related]
13. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
Gallardo G; Schlüter OM; Südhof TC
Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
McNaught KS; Olanow CW
Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
[TBL] [Abstract][Full Text] [Related]
15. Modeling proteasome dynamics in Parkinson's disease.
Sneppen K; Lizana L; Jensen MH; Pigolotti S; Otzen D
Phys Biol; 2009 May; 6(3):036005. PubMed ID: 19411740
[TBL] [Abstract][Full Text] [Related]
16. Role of iron in UPS impairment model of Parkinson's disease.
Le W
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S158-61. PubMed ID: 24262171
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathogenesis of Parkinson disease.
Eriksen JL; Wszolek Z; Petrucelli L
Arch Neurol; 2005 Mar; 62(3):353-7. PubMed ID: 15767499
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease, proteins, and prions: milestones.
Olanow CW; McNaught K
Mov Disord; 2011 May; 26(6):1056-71. PubMed ID: 21626551
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
Lee VM; Trojanowski JQ
Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]